Cardioversion and risk of adverse events with dabigatran versus warfarin: a nationwide cohort study

Jannik Langtved Pallisgaard, Tommi Bo Lindhardt, Morten Lock Hansen, Anne-Marie Schjerning, Jonas Bjerring Olesen, Laila Staerk, Christian Torp-Pedersen, Gunnar Hilmar Gislason

Research output: Contribution to journalJournal articleResearchpeer-review

23 Citations (Scopus)
279 Downloads (Pure)

Fingerprint Dive into the research topics of 'Cardioversion and risk of adverse events with dabigatran versus warfarin: a nationwide cohort study'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemical Compounds